US 8790652
Use of the combination of semaphorin-4D inhibitory molecules and VEGF inhibitory molecules to inhibit angiogenesis
granted A61KA61K2039/507A61K39/3955
Quick answer
US patent 8790652 (Use of the combination of semaphorin-4D inhibitory molecules and VEGF inhibitory molecules to inhibit angiogenesis) held by VACCINEX, INC. expires Mon Jul 24 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- VACCINEX, INC.
- Grant date
- Tue Jul 29 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 24 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K2039/507, A61K39/3955